Models to Medicine Series: From AI Drug Discovery to Patient Engagement

AWS for Startups invites you to an exclusive reception during #SFTechWeek, bringing together senior pharma leaders, life sciences investors, and AI-native biotech founders for an evening of conversation and connection. The centerpiece of the evening will be a moderated panel, "Models to Medicine," exploring how AI is transforming the full continuum from drug discovery and development to clinical care delivery. Panelists will share firsthand perspectives on scaling AI from the lab to the clinic, navigating the translation gap between computational models and clinical assets, and building productive partnerships across the pharma, healthcare, and tech ecosystem. This is an invitation-only gathering designed for candid, high-level dialogue among the pioneers defining the future of AI in life sciences and healthcare. Featured speakers: • Dr. Mary Rozenman, CBO/CFO, insitro • Dr. Bo Wang, Cofounder & Chief AI Scientist, Xaira Therapeutics • Janie Lee, VP of Product, Abridge • Jorge Conde, General Partner, a16z Moderated by: Max Garcia, Senior Account Manager for Frontier AI Sciences, AWS Why attend? • Hear from the frontier. Learn from a moderated panel with leaders who are actively scaling AI across the drug discovery pipeline, from computational models to clinical assets. • Curated, senior audience. Connect with healthcare and life sciences leaders, investors, and AI-native biotech founders in an intimate, invitation-only setting. • Actionable takeaways, not theory. Walk away with practical frameworks for evaluating AI readiness, structuring partnerships, and accelerating the path from model to market. This event is a part of #SFTechWeek—a week of events hosted by VCs and startups to bring together the tech ecosystem. Learn more at www.tech-week.com.

Are you the organiser? Get a private analytics link, and tell us if you are open to sponsors